BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25938033)

  • 1. Inhibitory effect of polysulfated heparin endostatin on alkali burn induced corneal neovascularization in rabbits.
    Li ZN; Yuan ZF; Mu GY; Hu M; Cao LJ; Zhang YL; Liu L; Ge MX
    Int J Ophthalmol; 2015; 8(2):234-8. PubMed ID: 25938033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits.
    Li ZN; Yuan ZF; Mu GY; Hu M; Cao LJ; Zhang YL; Ge MX
    Exp Ther Med; 2015 Sep; 10(3):889-894. PubMed ID: 26622410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
    Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
    Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor.
    Chen L; Zhong J; Li S; Li W; Wang B; Deng Y; Yuan J
    Drug Des Devel Ther; 2018; 12():2959-2969. PubMed ID: 30254425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
    Murata M; Shimizu S; Horiuchi S; Taira M
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):205-9. PubMed ID: 16044325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
    Gore A; Horwitz V; Cohen M; Gutman H; Cohen L; Gez R; Kadar T; Dachir S
    Exp Eye Res; 2018 Jun; 171():183-191. PubMed ID: 29548928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin.
    Sun F; Shaikh AS; Wang J; Gao H; Yang Z; Wang Z; Li Y; Wang F; Tan H
    Curr Pharm Biotechnol; 2018; 19(12):996-1004. PubMed ID: 30761959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model.
    Ge HY; Xiao N; Yin XL; Fu SB; Ge JY; Shi Y; Liu P
    Mol Vis; 2011; 17():1918-28. PubMed ID: 21850166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Conbercept on Corneal Neovascularization in a Rabbit Model.
    Du L; Sun J; Liu J; Xu N; Liu M; Wu X
    Semin Ophthalmol; 2023 Oct; 38(7):670-678. PubMed ID: 37058000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits.
    Kim EK; Kong SJ; Chung SK
    Cornea; 2014 Jan; 33(1):60-4. PubMed ID: 24240485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
    Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
    Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface.
    Cejkova J; Trosan P; Cejka C; Lencova A; Zajicova A; Javorkova E; Kubinova S; Sykova E; Holan V
    Exp Eye Res; 2013 Nov; 116():312-23. PubMed ID: 24145108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis.
    Abbas A; Khan B; Feroze AH; Hyman GF
    J Pak Med Assoc; 2002 Oct; 52(10):476-82. PubMed ID: 12553678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin.
    Ning TH; Chao CJ; Ying MG; Min X; Shan WF
    Pharmazie; 2012 Jul; 67(7):622-7. PubMed ID: 22888520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye.
    Zhou C; Singh A; Qian G; Wolkow N; Dohlman CH; Vavvas DG; Chodosh J; Paschalis EI
    Transl Vis Sci Technol; 2020 Jul; 9(8):5. PubMed ID: 32855852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model.
    Gore A; Kadar T; Cohen M; Gutman H; Gez R; Dachir S; Horwitz V
    Toxicol Rep; 2023; 10():206-215. PubMed ID: 36825253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.
    Chen P; Yin H; Wang Y; Mi J; He W; Xie L; Wang Y
    Mol Vis; 2010 Feb; 16():310-9. PubMed ID: 20208988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.